Bioinformatics for precision oncology
暂无分享,去创建一个
Niko Beerenwinkel | Jochen Singer | Hans-Joachim Ruscheweyh | Franziska Singer | Nora C. Toussaint | Nora C Toussaint | Mitchell P Levesque | Anja Irmisch | Daniel J Stekhoven | N. Beerenwinkel | D. Stekhoven | A. Irmisch | Hans-Joachim Ruscheweyh | M. Levesque | Jochen Singer | F. Singer
[1] Andrew E. Jaffe,et al. Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .
[2] Funda Meric-Bernstam,et al. Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Carme Camps,et al. Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service , 2017, PLoS medicine.
[4] A. Legat,et al. Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial , 2015, Clinical Cancer Research.
[5] Marilyn M. Li,et al. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. , 2017, The Journal of molecular diagnostics : JMD.
[6] Roman Rouzier,et al. Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials , 2015, Journal of the National Cancer Institute.
[7] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..
[8] Paolo Di Tommaso,et al. Nextflow enables reproducible computational workflows , 2017, Nature Biotechnology.
[9] Mauricio O. Carneiro,et al. From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.
[10] Deng Pan,et al. DGIdb 2.0: mining clinically relevant drug–gene interactions , 2015, Nucleic Acids Res..
[11] R. Altman,et al. Pharmacogenomics Knowledge for Personalized Medicine , 2012, Clinical pharmacology and therapeutics.
[12] Peiyong Guan,et al. Structural variation detection using next-generation sequencing data: A comparative technical review. , 2016, Methods.
[13] W. Koh,et al. Single-cell genome sequencing: current state of the science , 2016, Nature Reviews Genetics.
[14] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[15] J. Miller,et al. Predicting the Functional Effect of Amino Acid Substitutions and Indels , 2012, PloS one.
[16] Deanna M. Church,et al. ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..
[17] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[18] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[19] Moriah H Nissan,et al. OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.
[20] Vladimir Vacic,et al. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response. , 2015, JAMA oncology.
[21] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[22] David T. W. Jones,et al. Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study. , 2016, European journal of cancer.
[23] Jack Kuipers,et al. Detailed simulation of cancer exome sequencing data reveals differences and common limitations of variant callers , 2017, BMC Bioinformatics.
[24] Niko Beerenwinkel,et al. Genomic variant annotation workflow for clinical applications. , 2016, F1000Research.
[25] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[26] Q. Waisfisz,et al. Reflecting on Earlier Experiences with Unsolicited Findings: Points to Consider for Next-Generation Sequencing and Informed Consent in Diagnostics , 2013, Human mutation.
[27] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[28] Bernd Rinn,et al. NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysis , 2017, Bioinform..
[29] Wendy S. W. Wong,et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..
[30] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[31] B. Giusti,et al. EXCAVATOR: detecting copy number variants from whole-exome sequencing data , 2013, Genome Biology.
[32] Jos Jonkers,et al. CopywriteR: DNA copy number detection from off-target sequence data , 2015, Genome Biology.
[33] Ryan M. Layer,et al. LUMPY: a probabilistic framework for structural variant discovery , 2012, Genome Biology.
[34] A. Hauschild,et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.
[35] Peter J. Park,et al. Evaluation of somatic copy number estimation tools for whole-exome sequencing data , 2016, Briefings Bioinform..
[36] Razelle Kurzrock,et al. Breast Cancer Experience of the Molecular Tumor Board at the University of California, San Diego Moores Cancer Center. , 2015, Journal of oncology practice.
[37] Marie-Cécile Le Deley,et al. High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial. , 2017, Cancer discovery.
[38] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[39] Peter Bauer,et al. SeqPurge: highly-sensitive adapter trimming for paired-end NGS data , 2016, BMC Bioinformatics.
[40] B. Lane,et al. Development of a Center for Personalized Cancer Care at a Regional Cancer Center: Feasibility Trial of an Institutional Tumor Sequencing Advisory Board. , 2015, The Journal of molecular diagnostics : JMD.
[41] R. Gray,et al. Abstract CT101: NCI-molecular analysis for therapy choice (NCI-MATCH) clinical trial: interim analysis , 2016 .
[42] Cathy H. Wu,et al. UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..
[43] Gert Matthijs,et al. Guidelines for diagnostic next-generation sequencing , 2015, European Journal of Human Genetics.
[44] E. Boerwinkle,et al. dbNSFP v3.0: A One‐Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice‐Site SNVs , 2016, Human mutation.
[45] Sven Rahmann,et al. Genome analysis , 2022 .
[46] A. Nekrutenko,et al. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences , 2010, Genome Biology.
[47] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[48] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[49] M. Gerstung,et al. Reliable detection of subclonal single-nucleotide variants in tumour cell populations , 2012, Nature Communications.
[50] K. Russell,et al. Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE project , 2016, Genes & cancer.
[51] Funda Meric-Bernstam,et al. Bias from removing read duplication in ultra-deep sequencing experiments , 2014, Bioinform..
[52] S. Barry,et al. Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices , 2015, Scientific Reports.
[53] P. Park,et al. Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants , 2016, Nucleic acids research.
[54] Michael P. Schroeder,et al. In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. , 2015, Cancer cell.
[55] J. Potash,et al. Validation and assessment of variant calling pipelines for next-generation sequencing , 2014, Human Genomics.
[56] E. Boerwinkle,et al. dbNSFP: A Lightweight Database of Human Nonsynonymous SNPs and Their Functional Predictions , 2011, Human mutation.
[57] Birgit Funke,et al. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests. , 2015, Archives of pathology & laboratory medicine.
[58] Michael C. Heinold,et al. A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing , 2015, Nature Communications.
[59] Marina N Nikiforova,et al. Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists. , 2017, The Journal of molecular diagnostics : JMD.
[60] Mary Goldman,et al. Toil enables reproducible, open source, big biomedical data analyses , 2017, Nature Biotechnology.
[61] M. Morgante,et al. An Extensive Evaluation of Read Trimming Effects on Illumina NGS Data Analysis , 2013, PloS one.
[62] Bernard J. Pope,et al. Bpipe: a tool for running and managing bioinformatics pipelines , 2012, Bioinform..
[63] U. Kees,et al. Rare childhood cancers—an increasing entity requiring the need for global consensus and collaboration , 2015, Cancer medicine.
[64] Benjamin Schubert,et al. OptiType: precision HLA typing from next-generation sequencing data , 2014, Bioinform..
[65] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[66] L. Kvols,et al. A Phase II study of high‐dose paclitaxel in patients with advanced neuroendocrine tumors , 2001, Cancer.
[67] Lin He,et al. In-depth comparison of somatic point mutation callers based on different tumor next-generation sequencing depth data , 2016, Scientific Reports.
[68] Qingguo Wang,et al. Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives , 2013, BMC Bioinformatics.
[69] O. Delattre,et al. Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumors , 2017, Pediatric blood & cancer.
[70] A. Redig,et al. Basket trials and the evolution of clinical trial design in an era of genomic medicine. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] Nuno A. Fonseca,et al. Tools for mapping high-throughput sequencing data , 2012, Bioinform..
[72] Faraz Hach,et al. SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA , 2017, Bioinform..
[73] Kai Ye,et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..
[74] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[75] Steven J. M. Jones,et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer , 2017, Nature Genetics.
[76] Pablo Cingolani,et al. © 2012 Landes Bioscience. Do not distribute. , 2022 .
[77] Gavin R. Oliver,et al. Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery , 2017, OncoTarget.
[78] Marcel Martin. Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .
[79] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[80] J. Blay,et al. Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations. , 2015, The New England journal of medicine.
[81] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[82] Zhiyong Lu,et al. Text Mining Genotype-Phenotype Relationships from Biomedical Literature for Database Curation and Precision Medicine , 2016, PLoS Comput. Biol..
[83] Michael R. Speicher,et al. A survey of tools for variant analysis of next-generation genome sequencing data , 2013, Briefings Bioinform..
[84] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[85] Christopher A. Miller,et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.
[86] Michael P. Schroeder,et al. IntOGen-mutations identifies cancer drivers across tumor types , 2013, Nature Methods.
[87] J. Long,et al. Steps to ensure accuracy in genotype and SNP calling from Illumina sequencing data , 2012, BMC Genomics.
[88] Thomas Zichner,et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis , 2012, Bioinform..
[89] Michael Kalmbach,et al. Impact of post-alignment processing in variant discovery from whole exome data , 2016, BMC Bioinformatics.
[90] Sohrab P. Shah,et al. JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data , 2012, Bioinform..
[91] Peter J. Campbell,et al. Subclonal variant calling with multiple samples and prior knowledge , 2014, Bioinform..
[92] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[93] Cole Trapnell,et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.
[94] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[95] N. McGranahan,et al. The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.
[96] Sampsa Hautaniemi,et al. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data , 2015, Briefings Bioinform..
[97] Davis J. McCarthy,et al. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation , 2012, Nucleic acids research.
[98] Davide Prandi,et al. Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. , 2017, Cancer discovery.
[99] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[100] Emmanuel Barillot,et al. SVDetect: a tool to identify genomic structural variations from paired-end and mate-pair sequencing data , 2010, Bioinform..
[101] Stuart J. Andrews,et al. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations , 2016, Genome Medicine.
[102] K. Sirotkin,et al. dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. , 1999, Genome research.
[103] Gary D Bader,et al. Comprehensive identification of mutational cancer driver genes across 12 tumor types , 2013, Scientific Reports.
[104] A. Magi,et al. Detection of Genomic Structural Variants from Next-Generation Sequencing Data , 2015, Front. Bioeng. Biotechnol..
[105] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[106] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[107] S. Lippman,et al. Molecular tumor board: the University of California-San Diego Moores Cancer Center experience. , 2014, The oncologist.
[108] Mads Thomassen,et al. Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data , 2016, PloS one.
[109] Valentine Svensson,et al. Power Analysis of Single Cell RNA-Sequencing Experiments , 2016, Nature Methods.
[110] Benjamin J. Raphael,et al. Expanding the computational toolbox for mining cancer genomes , 2014, Nature Reviews Genetics.
[111] Eckart Meese,et al. DrugTargetInspector: An assistance tool for patient treatment stratification , 2016, International journal of cancer.
[112] Sven Rahmann,et al. Snakemake--a scalable bioinformatics workflow engine. , 2012, Bioinformatics.
[113] Benjamin M. Good,et al. Organizing knowledge to enable personalization of medicine in cancer , 2014, Genome Biology.
[114] J. Wolchok,et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.